The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010

Acta Ophthalmologica

Volumn 91, Issue 5, 2013, Pages

  Scanlon, Peter H ^a,b   Stratton, Irene M ^a,b   Histed, Mark ^a   Chave, Steve J ^a   Aldington, Stephen J ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

diabetic retinopathy; progression; risk factors; screening

Indexed keywords

ADULT; AGED; ARTICLE; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; EYE PHOTOGRAPHY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PREPROLIFERATIVE RETINOPATHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; RISK ASSESSMENT; SURVIVAL;

DIABETIC RETINOPATHY; PROGRESSION; RISK FACTORS; SCREENING;

AGED; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PHOTOGRAPHY; RETINA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84880265633     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12074     Document Type: Article

References (17)

1. Agardh E, &, Tababat-Khani P, (2011): Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34: 1318-1319.
2. Aldington SJ, Stratton IM, Matthews DR, &, Kohner EM, (1995): Relationship of retinal microaneurysm count to progression of retinopathy over 3 and 6 years in non-insulin dependent diabetes. Diabet Med 12 (Suppl 1): 3.
3. Chalk D, Pitt M, Vaidya B, &, Stein K, (2012): Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care 35: 1663-1668.
4. Chew EY, (2001): Surrogate outcomes for clinical trials: use with caution. Arch Ophthalmol 119: 576-578.
5. DH (2011): Integrated Performance Measures Monitoring. http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/ Performancedataandstatistics/Integratedperfomancemeasuresmonitoring/index.htm access date 05/03/12. City.
6. ETDRS (1991): Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (Suppl 5): 823-833.
7. Klein R, Meuer SM, Moss SE, &, Klein BE, (1995): Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol 113: 1386-1391.
8. Kohner EM, &, Sleightholm M, (1986): Does microaneurysm count reflect severity of early diabetic retinopathy? Ophthalmology 93: 586-589.
9. Kohner EM, Stratton IM, Aldington SJ, Turner RC, &, Matthews DR, (1999): Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 42: 1107-1112.
10. Kohner EM, Stratton IM, Aldington SJ, Holman RR, &, Matthews DR, (2001): Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 18: 178-184.
11. Mehlsen J, Erlandsen M, Poulsen PL, &, Bek T, (2011): Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 89: 515-521.
12. Mehlsen J, Erlandsen M, Poulsen PL, &, Bek T, (2012): Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol 90: 109-114.
13. Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, &, Cunha-Vaz J, (2009): Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica 223: 292-297.
14. Olafsdottir E, &, Stefansson E, (2007): Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91: 1599-1601.
15. Stratton IM, Aldington SJ, Taylor DJ, Adler AI, &, Scanlon PH, (2012): A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy. Diabetes Care. [Epub ahead of print]
16. Younis N, Broadbent DM, Harding SP, &, Vora JP, (2003a): Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 20: 758-765.
17. Younis N, Broadbent DM, Vora JP, &, Harding SP, (2003b): Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361: 195-200.